6 months ago
Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
Download Sample Copy@ https://tinyurl.com/2ufp9k...
The stem cells industry data book is a combination of the market data from five reports namely, the stem cells market, human embryonic stem cells market, induced pluripotent stem cells production market, mesenchymal stem cells market, and cancer stem cells market. The stem cells market was valued at USD 13.26 Billion in 2022 with a CAGR of 11.4% during 2023-2030. The induced pluripotent stem cells production market was valued at USD 1.36 Billion in 2022 with a CAGR of 9.3% during 2023-2030. The human embryonic stem cells market was valued at USD 1.10 Billion in 2022 with a CAGR of 10.6% during 2023-2030. The mesenchymal stem cells market was valued at USD 3.02 Billion in 2022 with a CAGR of 11.4% during 2023-2030. Cancer stem cells market was valued at USD 2.59 Billion in 2022 with a CAGR of 12.1% during 2023-2030.
The stem cell market is anticipated to be driven primarily by the expanding development of precision medicine, growth in the number of cell therapy production facilities, and expansion in the number of clinical trials. Recent developments in tissue engineering and stem cell therapy have the potential to attract attention for the treatment of a number of chronic diseases. Additionally, increasing research activities into the synthesis, storage, and characterization of stem cells as well as rising demand for stem cell banking are anticipated to support the market's revenue growth.
#StemCellBreakthroughs #RegenerativeMedicine2030 #MedicalInnovation2023 #FutureOfHealthcare #StemCellTherapies #AdvancingMedicine #RegenerationRevolution #HealthcareTransformation #CellularTherapies #StemCellResearch
Download Sample Copy@ https://tinyurl.com/2ufp9k...
The stem cells industry data book is a combination of the market data from five reports namely, the stem cells market, human embryonic stem cells market, induced pluripotent stem cells production market, mesenchymal stem cells market, and cancer stem cells market. The stem cells market was valued at USD 13.26 Billion in 2022 with a CAGR of 11.4% during 2023-2030. The induced pluripotent stem cells production market was valued at USD 1.36 Billion in 2022 with a CAGR of 9.3% during 2023-2030. The human embryonic stem cells market was valued at USD 1.10 Billion in 2022 with a CAGR of 10.6% during 2023-2030. The mesenchymal stem cells market was valued at USD 3.02 Billion in 2022 with a CAGR of 11.4% during 2023-2030. Cancer stem cells market was valued at USD 2.59 Billion in 2022 with a CAGR of 12.1% during 2023-2030.
The stem cell market is anticipated to be driven primarily by the expanding development of precision medicine, growth in the number of cell therapy production facilities, and expansion in the number of clinical trials. Recent developments in tissue engineering and stem cell therapy have the potential to attract attention for the treatment of a number of chronic diseases. Additionally, increasing research activities into the synthesis, storage, and characterization of stem cells as well as rising demand for stem cell banking are anticipated to support the market's revenue growth.
#StemCellBreakthroughs #RegenerativeMedicine2030 #MedicalInnovation2023 #FutureOfHealthcare #StemCellTherapies #AdvancingMedicine #RegenerationRevolution #HealthcareTransformation #CellularTherapies #StemCellResearch
6 months ago
Digital Health Industry Data Book - Tele-Healthcare, mHealth, Healthcare Analytics and Digital Health System Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030
Download Sample Copy@ https://tinyurl.com/3c8tuk...
The global mHealth market size was valued at USD 56.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2023 to 2030. The major factors that are attributing the market growth are growing adoption of smartphones for personal health and fitness and rising penetration rate of the internet. Other factors like growing preferences of mHealth technology and platforms by physicians and patients and rising penetration of digital health services for remote patient monitoring are projected to fuel the market growth over the forecast period.
Shifting trend of adopting patient centric and preventive approaches from conventional healthcare practices are also expected to drive the market growth. For instance, as per the statistics published in a digital health journal in 2020, about 64% approved on the benefit of tracking medical treatment, and 68% of users agreed that the apps which retrieve EMR remotely are highly valuable for a healthy lifestyle. Increasing investment by government and non-government organizations in expanding digital healthcare sector further boosts the market growth. The market gained major traction during COVID-19 as large number of patients and doctors opted for mHealth platforms during that time frame owing to infection fears and lock down scenarios globally. Increasing strategic alliances between manufacturers and healthcare institutions is also expected to support the market growth. For instance, collaboration between Philips and American Telemedicine Association (ATA) in 2020 helped in increasing adoption of mHealth during COVID-19.
#DigitalHealthRevolution #HealthcareInnovation2022 #FutureofHealthTech #TransformingHealthcare2030 #DigitalHealthTrends #HealthTechAdvancements #PatientCentricCare #TechInMedicine #HealthcareTransformation #DigitalHealth2022
Download Sample Copy@ https://tinyurl.com/3c8tuk...
The global mHealth market size was valued at USD 56.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2023 to 2030. The major factors that are attributing the market growth are growing adoption of smartphones for personal health and fitness and rising penetration rate of the internet. Other factors like growing preferences of mHealth technology and platforms by physicians and patients and rising penetration of digital health services for remote patient monitoring are projected to fuel the market growth over the forecast period.
Shifting trend of adopting patient centric and preventive approaches from conventional healthcare practices are also expected to drive the market growth. For instance, as per the statistics published in a digital health journal in 2020, about 64% approved on the benefit of tracking medical treatment, and 68% of users agreed that the apps which retrieve EMR remotely are highly valuable for a healthy lifestyle. Increasing investment by government and non-government organizations in expanding digital healthcare sector further boosts the market growth. The market gained major traction during COVID-19 as large number of patients and doctors opted for mHealth platforms during that time frame owing to infection fears and lock down scenarios globally. Increasing strategic alliances between manufacturers and healthcare institutions is also expected to support the market growth. For instance, collaboration between Philips and American Telemedicine Association (ATA) in 2020 helped in increasing adoption of mHealth during COVID-19.
#DigitalHealthRevolution #HealthcareInnovation2022 #FutureofHealthTech #TransformingHealthcare2030 #DigitalHealthTrends #HealthTechAdvancements #PatientCentricCare #TechInMedicine #HealthcareTransformation #DigitalHealth2022
